Affinity-Oligonucleotide Conjugates for Single-Cell Sequencing

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current flow cytometry-based methods for immunophenotyping are limited by the number of fluorophores that can be used concurrently and suffer from spectral overlap, making them inadequate for biologically relevant assays and DNA sequencing.

Innovation Solution

The use of affinity-oligonucleotide conjugates, such as antibody-oligonucleotide or tetramer-oligonucleotide conjugates, which allow for the analysis of proteins in individual cells through sequence readouts without the need for fluorophores, enabling the identification of surface proteins, T cell receptors, and B cell receptors, and determining their binding affinities.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If flow cytometry-based approaches are used for immunophenotyping, then cell surface proteins can be identified and categorized, but the number of fluorophores that can be used concurrently is limited and spectral overlap occurs

Engineering Contradiction:
Improvecell surface protein identification accuracyVSAvoidfluorophore spectral overlap
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent replaces the optical detection system (flow cytometry with fluorophores) with a sequence-based detection system. Affinity molecules are conjugated to oligonucleotide barcodes that can be identified through DNA sequencing, eliminating the need for fluorophores and spectral resolution while enabling higher multiplexing capacity through the vast diversity of nucleotide sequences.

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If flow cytometry is used for cell analysis, then surface-bound antibodies can be measured, but the method is not amenable to DNA sequencing and biologically-relevant assays

Engineering Contradiction:
Improvesurface antibody measurementVSAvoidassay compatibility
Core Design Contradiction:
Measurement precisionVSAdaptability or versatility

Solution Approach 1:

The patent merges affinity-based cell surface protein detection with sequence-based identification. By conjugating affinity molecules (antibodies, antigen-binding fragments) to oligonucleotide barcodes, the system combines the specificity of affinity binding with the versatility of nucleic acid technologies, enabling compatibility with DNA sequencing, PCR, and other biologically-relevant assays.

Inventive Principle:
Principle #5Merging (Combining)

3Measurement precision

If cell sorting is performed to characterize single cells, then cell identity can be determined, but the process is slow and reduces target yield

Engineering Contradiction:
Improvesingle cell characterization accuracyVSAvoidcell sorting speed and yield
Core Design Contradiction:
Measurement precisionVSProductivity

Solution Approach 1:

The patent uses oligonucleotide barcodes as molecular copies or proxies for cell surface proteins. Instead of physically sorting cells based on surface markers, the method attaches sequence-based barcodes to cells via affinity binding, then sequences the barcodes to identify cell phenotypes. This copying approach eliminates slow physical sorting while preserving single-cell resolution and target yield.

Inventive Principle:
Principle #26Copying

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach overcomes limitations of flow cytometry by allowing for the characterization of single cells without fluorophore constraints, facilitating simultaneous measurement of TCR pair sequences, clone abundance, and relative tetramer affinities, and is compatible with emulsion-based single-cell analysis and subsequent DNA sequencing.

Implementation Method 1

the affinity portion of the affinity-oligonucleotide conjugate specifically binds to a target antigen of a single cell

Methodology Applied
Scientific EffectSpecific binding:

Data Source

PatentEP3516069B1Affinity-oligonucleotide conjugates and uses thereof
Publication Date: 2023.10.11 ABVITRO LLC
  • EP3516069B1 patent drawingFigure 1
  • EP3516069B1 patent drawingFigure 2
  • EP3516069B1 patent drawingFigure 3A~3B

AI summary

Provided herein are methods and compositions for single cell characterization using affinity-oligonucleotide conjugates. Provided herein are methods and compositions for single cell charaterization using tetramer-oligonucleotide conjugates.